Avid Bioservices Inc (CDMO)

[Protector]

bidrite, they have almost NEVER told us what they would do in the future, why would they now and put themselves in the strategic disadvantage.

One example know well by ALL on here:

2nd ln NSCLC fail (according many) and would NEVER get through FDA approval for a PIII (since the data was corrupted etc etc etc you remember all the doom about that).

YET, suddenly a PR that they salvaged the data (they NEVER ANNOUNCED THAT...they said they were going to INVESTIGATE!). And a little later, boom...an FDA PIII approval for SUNRISE and they NEVER told us they filed for a PIII! And YET a little later again BOOM...an FDA Fast Track Grant...and the NEVER told us they filed for one.

However during that COMPLETE period the PPS dropped from 5.40$ to a range between 0.65 and 1.25$ (we some exceptional peek on no news) and you could say what you just said:

...else could have told us by now.

Why, if in identical conditions PPHM preferred the surprise tactics, possibly to deceive the competition because we know from PACER that PPHM in the end ALSO believe in WILLING TEMPERING with the 2nd ln NSCLC and added fraud and constructive fraud to the complaint, would they not do the same now.

They maid a financing move with Eastern Capital that points in a 'bridging' manoeuvre. We didn't hear Dr. Garnick and PPHM choose words very carefully "STOP SUNRISE TRIAL (NOT THE STUDY which is what must be approved based on ALL activities that where part of it even starting pre-clinical and PI/II/III). The TEMPORARY put other CHEMO trials on hold...why if the control arm outperformed and it is an OCCASIONAL ANOMALY then why would you stop the OTHER CHEMO trials? You would do that if you suspect the anomaly not going to be occasional.

And why would Shan makes these statements if PPHM didn't really make that part of their design?

We obviously have some stratification criteria built in and some preplanned, subgroup analyses that are going to be pre-specified.

So tell me, if they have done the above (and some more as quoted in my previous post) then why would they not USE IT? If there would not have been a SUNRISE STOP they wouldn't need these things as they were SPECIFICALLY DESIGNED baring in mind the outperforming of the control arm due to Opdivo/Keytruda treatments.

So I don't see what is so extraordinary about my reasoning that we could have a surprise, the more that Bavi arm patients have the choice to stay on Bavi and the SUNRISE trial is still active.